Key facts
- It has raised $470K; the latest was Early Stage VC ($470K) in Feb 2026.
- Notable investors include Corallia Ventures, Elevate Greece, Hellenic Business Angels Network, Pablo David.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Althexis
- ·The full record, as it builds
Funding rounds
No funding rounds for Althexis are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Althexis
Developer of a digital health platform designed to empower physical pharmacies and skincare brands with AI-powered skin analysis and data-driven sales optimization. The company offers a blend of medical-grade multispectral dermoscopy and smart sales assistants, enabling customers to provide personalized, science-backed skincare consultations that drive high-margin in-store sales and foster long-term loyalty through objective data.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Athens, Greece
- Founded
- 2022
- Employees
- 4
- Website
- althexis.com/
- Ownership
- Privately Held (backing)
Althexis doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Althexis shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Althexis in its N-PORT filings yet. We sweep new filings monthly.